Press Releases
Calidi is at the forefront of the genetic medicine revolution in cancer and other indications
Read the Latest
Scientific Advisory Board Member Interview – Ashok Srivastava, M.D./Ph.D.
Scientific Advisory Board Member Interview – Santosh Kesari, M.D./Ph.D.
Scientific Advisory Board Member Interview – W.K. Alfred Yung, M.D.
Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board
Antonio Chiocca, M.D., Ph.D., Chair, Department of Neurosurgery at Brigham and Women’s Hospital, Co-Director, Institute…
Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit
SAN DIEGO–(December 13, 2023)–Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company…